Nafpenzal DC Intramammary Suspension
Nafpenzal DC Intramammary Suspension
Not authorised
- Benzylpenicillin procaine
- Dihydrostreptomycin sulfate
- Nafcillin sodium
Product identification
Medicine name:
Nafpenzal DC Intramammary Suspension
Active substance:
- Benzylpenicillin procaine
- Dihydrostreptomycin sulfate
- Nafcillin sodium
Target species:
-
Cattle
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Benzylpenicillin procaine300.00milligram(s)1.00Syringe
-
Dihydrostreptomycin sulfate116.81milligram(s)1.00Syringe
-
Nafcillin sodium105.31milligram(s)1.00Syringe
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
-
Cattle
-
Meat and offal14day
-
Milk48hour
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51RC23
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Ireland
Package description:
- Each 3 g syringe is made of low density polyethylene. The syringes are packed in a sachet. The sachet is packed in a carton. Cleaning towels packed in a sachet are also included in the carton. Packs of 20 syringes and 20 cleaning towels.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Intervet (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Intervet International B.V.
Responsible authority:
- Health Products Regulatory Authority
Authorisation number:
- VPA10996/074/001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 3/05/2024
How useful was this page?: